323 related articles for article (PubMed ID: 10357554)
1. Successful management of microscopic residual disease in large bowel cancer.
Sugarbaker PH
Cancer Chemother Pharmacol; 1999; 43 Suppl():S15-25. PubMed ID: 10357554
[TBL] [Abstract][Full Text] [Related]
2. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
3. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?
Terzi C; Arslan NC; Canda AE
World J Gastroenterol; 2014 Oct; 20(39):14371-80. PubMed ID: 25339824
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.
Carmignani CP; Sugarbaker PH
Expert Rev Anticancer Ther; 2004 Jun; 4(3):477-87. PubMed ID: 15161446
[TBL] [Abstract][Full Text] [Related]
6. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.
Portilla AG; Sugarbaker PH; Chang D
World J Surg; 1999 Jan; 23(1):23-9. PubMed ID: 9841759
[TBL] [Abstract][Full Text] [Related]
7. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
[TBL] [Abstract][Full Text] [Related]
8. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
10. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
Paul BK; Ihemelandu C; Sugarbaker PH
Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
[TBL] [Abstract][Full Text] [Related]
11. Surgery for colorectal peritoneal carcinomatosis.
Chua TC; Pelz JO; Morris DL
Scand J Gastroenterol; 2012 Mar; 47(3):277-85. PubMed ID: 22263634
[TBL] [Abstract][Full Text] [Related]
12. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer.
Sugarbaker PH
World J Surg; 1995; 19(2):235-40. PubMed ID: 7754629
[TBL] [Abstract][Full Text] [Related]
13. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity.
Roviello F; Marrelli D; Neri A; Cerretani D; de Manzoni G; Pedrazzani C; Cioppa T; Nastri G; Giorgi G; Pinto E
World J Surg; 2006 Nov; 30(11):2033-40; discussion 2041-2. PubMed ID: 17006608
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
16. Indication of peritonectomy for peritoneal dissemination.
Yonemura Y; Tsukiyama G; Miyata R; Sako S; Endou Y; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Hagiwara A; Li Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2306-11. PubMed ID: 21224556
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
18. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
20. Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.
Cotte E; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O
Cancer J; 2009; 15(3):243-8. PubMed ID: 19556911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
